drugset / Trial / NCT04600037

Pregabalin Treatment for Trigger Points

NCT04600037

RandomizedParallel-groupSingle-blindOther

Summary

Myofascial pain syndrome (MPS) is a common problem in the general population. MPS should not be a local/peripheral painful syndrome and considered to be a syndrome of central sensitivity. We aimed to investigate the effect of pregabalin in patients with MPS in this study

Timeline

Start
2014-04-26
Primary completion
2014-07-26
Completion
2015-01-26

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pregabalin Small molecule 150 mg